$2.03 Billion is the total value of Novo Holdings A/S's 54 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 17.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDStotal stk mkt | $287,749,000 | -17.2% | 1,525,550 | 0.0% | 14.17% | -22.7% | |
| CTLT | Buy | CATALENT INC | $175,191,000 | +24.2% | 1,632,878 | +28.4% | 8.63% | +16.0% |
| SYK | New | STRYKER CORPORATION | $158,535,000 | – | 796,941 | +100.0% | 7.81% | – |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $130,773,000 | -14.8% | 3,508,788 | +1.3% | 6.44% | -20.4% |
| BAM | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $129,904,000 | -21.4% | 2,921,171 | 0.0% | 6.40% | -26.6% | |
| ASML | Sell | ASML HOLDING N V | $102,314,000 | -28.8% | 215,000 | -0.0% | 5.04% | -33.5% |
| STE | New | STERIS PLC | $96,414,000 | – | 467,687 | +100.0% | 4.75% | – |
| CRM | Buy | SALESFORCE.COM, INC. | $78,972,000 | +24.4% | 478,500 | +60.0% | 3.89% | +16.1% |
| ARCELLX, INC. | $72,625,000 | +29.0% | 4,016,878 | 0.0% | 3.58% | +20.4% | ||
| AAPL | Sell | APPLE INC | $63,080,000 | -40.9% | 461,379 | -24.5% | 3.11% | -44.8% |
| CORT | New | CORCEPT THERAPEUTICS INC | $60,080,000 | – | 2,526,490 | +100.0% | 2.96% | – |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $58,106,000 | +21.5% | 710,780 | +54.9% | 2.86% | +13.4% |
| CABO | Buy | CABLE ONE INC | $57,340,000 | +146.7% | 44,473 | +180.2% | 2.82% | +130.3% |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $56,934,000 | +4.5% | 500,827 | 0.0% | 2.80% | -2.4% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $44,474,000 | -17.9% | 5,587,207 | 0.0% | 2.19% | -23.4% | |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $37,931,000 | -21.7% | 2,027,324 | -7.8% | 1.87% | -26.9% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $28,300,000 | +16.7% | 2,635,000 | +2.9% | 1.39% | +9.0% |
| NKTX | Sell | NKARTA INC | $26,858,000 | -15.5% | 2,180,000 | -22.0% | 1.32% | -21.1% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $26,311,000 | – | 317,500 | +100.0% | 1.30% | – |
| VECT | Sell | VECTIVBIO HLDG AG | $18,033,000 | +13.3% | 3,339,484 | -1.2% | 0.89% | +5.7% |
| PCVX | New | VAXCYTE INC | $17,924,000 | – | 823,705 | +100.0% | 0.88% | – |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $15,995,000 | +10.1% | 316,674 | +39.2% | 0.79% | +2.7% |
| MIST | MILESTONE PHARMACEUTICALS IN | $15,560,000 | -4.2% | 2,530,003 | 0.0% | 0.77% | -10.6% | |
| IO BIOTECH INC | $15,308,000 | -11.9% | 3,277,932 | 0.0% | 0.75% | -17.7% | ||
| INSM | Buy | INSMED INC | $15,184,000 | -8.5% | 770,000 | +9.1% | 0.75% | -14.5% |
| CYT | CYTEIR THERAPEUTICS INC | $14,473,000 | -20.7% | 4,840,413 | 0.0% | 0.71% | -26.0% | |
| NARI | Buy | INARI MED INC | $14,278,000 | +27.9% | 210,000 | +70.6% | 0.70% | +19.4% |
| VERV | Buy | VERVE THERAPEUTICS INC | $14,166,000 | -17.2% | 927,100 | +23.6% | 0.70% | -22.7% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $12,368,000 | +203.0% | 84,800 | +239.2% | 0.61% | +183.3% |
| MORF | Sell | MORPHIC HLDG INC | $12,266,000 | -81.3% | 565,237 | -65.4% | 0.60% | -82.6% |
| ABCL | New | ABCELLERA BIOLOGICS INC | $12,002,000 | – | 1,126,915 | +100.0% | 0.59% | – |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $11,780,000 | +26.3% | 631,627 | +48.7% | 0.58% | +17.9% |
| PHVS | Buy | PHARVARIS N V | $11,477,000 | +22.5% | 519,339 | +0.6% | 0.56% | +14.4% |
| INGN | Sell | INOGEN INC | $11,194,000 | -67.8% | 462,949 | -56.8% | 0.55% | -70.0% |
| INSP | Buy | INSPIRE MED SYS INC | $10,303,000 | -3.2% | 56,400 | +36.1% | 0.51% | -9.6% |
| KNTE | Buy | KINNATE BIOPHARMA INC | $10,286,000 | +46.3% | 815,707 | +30.7% | 0.51% | +36.7% |
| SILK | Sell | SILK RD MED INC | $10,026,000 | -12.0% | 275,511 | -0.2% | 0.49% | -17.8% |
| LVTX | LAVA THERAPEUTICS NV | $9,816,000 | -33.0% | 3,327,312 | 0.0% | 0.48% | -37.4% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $9,188,000 | -25.5% | 4,503,991 | 0.0% | 0.45% | -30.6% | |
| RPHM | RENEO PHARMACEUTICALS INC | $9,090,000 | -9.9% | 3,430,377 | 0.0% | 0.45% | -15.8% | |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $8,708,000 | -10.4% | 632,822 | +3.3% | 0.43% | -16.4% |
| TMCI | Buy | TREACE MED CONCEPTS INC | $8,436,000 | -10.9% | 588,308 | +17.6% | 0.42% | -16.8% |
| SPRB | SPRUCE BIOSCIENCES INC | $7,855,000 | -13.4% | 4,514,336 | 0.0% | 0.39% | -19.2% | |
| LUNG | Buy | PULMONX CORP | $7,515,000 | -26.1% | 510,555 | +24.5% | 0.37% | -31.1% |
| AKUS | AKOUOS INC | $4,981,000 | -1.2% | 1,061,990 | 0.0% | 0.24% | -7.9% | |
| Buy | RALLYBIO CORP | $4,870,000 | +60.0% | 645,021 | +48.0% | 0.24% | +49.1% | |
| MINERVA SURGICAL INC | $4,815,000 | -47.8% | 2,048,892 | 0.0% | 0.24% | -51.2% | ||
| GLTO | GALECTO INC | $4,321,000 | -21.4% | 2,497,791 | 0.0% | 0.21% | -26.6% | |
| SPNE | Sell | SEASPINE HLDGS CORP | $3,925,000 | -62.4% | 694,677 | -19.1% | 0.19% | -65.0% |
| MQ | MARQETA INC | $3,581,000 | -26.5% | 441,558 | 0.0% | 0.18% | -31.5% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $3,189,000 | -16.0% | 761,205 | 0.0% | 0.16% | -21.5% | |
| GRTX | GALERA THERAPEUTICS INC | $3,197,000 | -45.4% | 2,459,021 | 0.0% | 0.16% | -49.2% | |
| ALGS | ALIGOS THERAPEUTICS INC | $2,360,000 | -43.7% | 1,950,000 | 0.0% | 0.12% | -47.5% | |
| SPRO | SPERO THERAPEUTICS INC | $347,000 | -91.5% | 468,902 | 0.0% | 0.02% | -92.1% | |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -250,000 | -100.0% | -0.14% | – |
| CMPI | Exit | CHECKMATE PHARMACEUTICALS IN | $0 | – | -2,161,990 | -100.0% | -0.36% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -836,518 | -100.0% | -0.74% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.